Novartis, Pfizer among drug makers giving thumbs-up to Facebook ad boycott
A number of pharma companies are pausing ads on the social network this month, either in solidarity with #StopHateForProfit’s July boycott or due to brand safety concerns.
Most recent articles by Marc Iskowitz
Pharma brands tweak media mix to align with their stance on racism
As drug makers mull whether to join a July ad boycott against Facebook, will #BLM prove a tipping point for health brands’ new social activism?
An updated guide to how pharma and agencies are reacting to George Floyd’s death
This list will be updated regularly as industry responds to the death of Floyd and other black victims of police brutality.
For biotech CEO Dr. Ted Love, confronting white privilege is nothing new
Human rights should be a litmus test for leaders, said Dr. Love, CEO of Global Blood Therapeutics.
‘It rekindles such deep-seated pain.’ CMI/Compas’ Stan Woodland on the death of George Floyd and teaching health marketers to be anti-racist
The CEO reflects on what has become an all-too-familiar pain for African Americans, and how he’s sparking change in the healthcare marketing community.
Agency 100 2020: Klick Health
Revenue rose 20% to an MM&M-estimated $345 million in 2019.
